A detailed history of Prospera Financial Services Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Prospera Financial Services Inc holds 3,083 shares of MRNA stock, worth $113,608. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,083
Previous 16,756 81.6%
Holding current value
$113,608
Previous $1.99 Million 89.64%
% of portfolio
0.01%
Previous 0.06%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$63.64 - $125.14 $870,149 - $1.71 Million
-13,673 Reduced 81.6%
3,083 $206,000
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $1.33 Million - $2.19 Million
13,121 Added 360.96%
16,756 $1.99 Million
Q1 2024

Aug 13, 2024

SELL
$85.37 - $115.44 $1.12 Million - $1.51 Million
-13,093 Reduced 78.14%
3,663 $390,000
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $57,623 - $86,572
-829 Reduced 18.57%
3,635 $361,000
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $74,910 - $98,375
-777 Reduced 14.83%
4,464 $461,000
Q2 2023

Aug 08, 2023

SELL
$118.5 - $160.53 $102,265 - $138,537
-863 Reduced 14.14%
5,241 $636,000
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $1.02 Million - $1.48 Million
-7,509 Reduced 55.16%
6,104 $937,000
Q4 2022

Feb 08, 2023

BUY
$118.38 - $210.04 $972,373 - $1.73 Million
8,214 Added 152.14%
13,613 $2.45 Million
Q3 2022

Oct 27, 2022

BUY
$118.07 - $194.18 $367,551 - $604,482
3,113 Added 136.18%
5,399 $639,000
Q2 2022

Aug 08, 2022

SELL
$117.13 - $176.59 $61,258 - $92,356
-523 Reduced 18.62%
2,286 $327,000
Q1 2022

May 04, 2022

BUY
$126.46 - $235.05 $13,404 - $24,915
106 Added 3.92%
2,809 $484,000
Q4 2021

Feb 10, 2022

SELL
$225.82 - $368.51 $729,398 - $1.19 Million
-3,230 Reduced 54.44%
2,703 $687,000
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $85,209 - $186,036
384 Added 6.92%
5,933 $2.28 Million
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $185,251 - $335,081
1,426 Added 34.59%
5,549 $1.3 Million
Q1 2021

May 06, 2021

BUY
$109.18 - $185.98 $15,831 - $26,967
145 Added 3.65%
4,123 $539,000
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $250,009 - $645,977
3,803 Added 2173.14%
3,978 $415,000
Q3 2020

Nov 04, 2020

BUY
$54.34 - $94.85 $9,509 - $16,598
175 New
175 $12,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.